No Detail Found!

Assessment of abnormalities in lipoprotein components in hyperlipidemic, diabetic and non-diabetic patients

Author(s)
Junaid Mahmood Alam Biochemistry Laboratory Services, Liaquat National Hospital & Medical College, Karachi, PAKISTAN
Rabia Shaheen Biochemistry Laboratory Services, Liaquat National Hospital & Medical College, Karachi, PAKISTAN
Ishrat Sultana Biochemistry Laboratory Services, Liaquat National Hospital & Medical College, Karachi, PAKISTAN
Jawaid Altaf Baig Department of Biochemisry and Community Medicine, Liaquat National Hospital & Medical College, Karachi, PAKISTAN
Tahseen Kazmi Department of Biochemistry and Community Medicine Liaquat National Hospital & Medical College, Karachi, PAKISTAN
Maqsood Ali Ansari Department of Genetics, University of Karachi, Karachi, PAKISTAN
Suad Naheed HEJ Research Institute of Chemistry, University of Karachi, Karachi, Pakistan
Siddiqa Jamall HEJ Research Institute of Chemistry, University of Karachi, Karachi, Pakistan
Abstract
Hyperlipoproteinaemia is a metabolic abnormality and mainly modulated by apolipoproteins. Furthermore, lipoprotein abnormalities contribute significantly to the risk of development of cardiovascular disease and diabetes mellitus. Additionally, abnormal glycemic state, lipid and lipoprotein abnormalities have been shown to be important contributors to early atherosclerosis. Present study evaluates the status of low density lipoprotein, high density lipoprotein, apolipo-protein A and B in hyperlipidemic, diabeteic and non-diabetic patients. Total 69 patients of both gender, sub-grouped as 39 non-diabetic hyperlipidemic (NDHL) and 30 diabetic hyperlipidemic (DHL) patients were included in the study. Total cholesterol and Apo B was noted to be significantly higher in DHL than NDHL patients. Moreover, levels of Apo B was higher thanApoA in both DHL and NDHL groups when compared with healthy group. Elevated levels of both triglyceride and total cholesterol in both DHL and NDHL groups depicts a strong hyperlipidemic state. It is concluded that diabetes and hyperlipidemia are important risk factors for the onset of cardiac abnormalities. Additionally higher levels of Apo B and A and that of higher Apo B than Apo A are indicative of dyslipidemic state and thus significant parameters for assessing the prevailing conditions and extent of risk for developing coronary heart disease (CHD) and atherosclerosis.
Publication Details
Page(s) 195-199
DOI DOI not available
Published Journal: Pakistan Journal of Biochemistry and Molecular Biology , Volume: 43, Issue: 4, Year: 2010

Request the full text from PASTIC

0

Citations

0

Downloads

39

Views